---
figid: PMC12187357__bmef.0144.fig.005
figtitle: Signaling pathways responsible for EMT-induced drug resistance in HCC
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC12187357
filename: bmef.0144.fig.005.jpg
figlink: /pmc/articles/PMC12187357/figure/F5/
number: F5
caption: Signaling pathways responsible for EMT-induced drug resistance in HCC. (A)
  TGF-β signaling pathway induces EMT by prompting β-catenin accumulation in the nucleus
  and enhancing SMAD2, SMAD4, and SMAD3 expression, which results in sorafenib and
  doxorubicin resistance in HCC. (B) The EGFR signaling pathway induces drug resistance
  in HCC by affecting the EMT mechanism through the FAK/PI3K/AKT and H-Ras/Raf/ERK
  pathways and increasing the phosphorylation of AKT, mTOR, and p70 kinases
papertitle: 'Revisiting Treatment Strategies: Addressing Epithelial-to-Mesenchymal
  Transition-Induced Resistance in Hepatocellular Carcinoma'
reftext: Roghayeh Naserkhaki, et al. BME Front. 2025 Jun 24;6(NA).
year: '2025'
doi: 10.34133/bmef.0144
journal_title: BME Frontiers
journal_nlm_ta: BME Front
publisher_name: AAAS Science Partner Journal Program
keywords: ''
automl_pathway: 0.9664069
figid_alias: PMC12187357__F5
figtype: Figure
redirect_from: /figures/PMC12187357__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12187357__bmef.0144.fig.005.html
  '@type': Dataset
  description: Signaling pathways responsible for EMT-induced drug resistance in HCC.
    (A) TGF-β signaling pathway induces EMT by prompting β-catenin accumulation in
    the nucleus and enhancing SMAD2, SMAD4, and SMAD3 expression, which results in
    sorafenib and doxorubicin resistance in HCC. (B) The EGFR signaling pathway induces
    drug resistance in HCC by affecting the EMT mechanism through the FAK/PI3K/AKT
    and H-Ras/Raf/ERK pathways and increasing the phosphorylation of AKT, mTOR, and
    p70 kinases
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TGFB1
  - TGFB2
  - TGFB3
  - EGFR
  - EGF
  - VPS37A
  - MIR145
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PTK2
  - AKT1
  - AKT2
  - AKT3
  - SMAD2
  - CTNNB1
  - SMAD3
  - SMAD4
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - EPHB2
  - MAPK1
  - MAPK3
  - HRAS
  - ANXA6
  - UBASH3B
  - MTOR
  - ITK
  - SLC22A3
  - CDH1
  - FZR1
  - CEMIP
  - SNAI1
  - TWIST1
  - EGF
  - doxorubicin
  - Doxorubicin
---
